← Back to home

ACCESS TO TREATMENT

Treatment of FIP with GS-441524

FIP, Feline Infectious Peritonitis, is a serious disease associated with feline coronavirus and, in the absence of effective treatment, may have a fatal course.

In recent years, GS-441524 has fundamentally changed therapeutic prospects for many cats with FIP.

Cat in a calm, familiar environment

01

Access through a veterinary prescription

In the European Union, veterinary medicines legislation allows a veterinarian, in certain situations and under their direct professional responsibility, to use therapeutic options outside the range of veterinary products normally authorised, in accordance with the so-called therapeutic cascade.

Within this framework, where the applicable conditions are met, veterinary preparations compounded extemporaneously by a pharmacy may be prescribed on the basis of a prescription for the individual animal.

02

Pharmacie Delpech Paris

Pharmacie Delpech in Paris, founded in 1873, compounds veterinary preparations based on GS-441524 for the treatment of FIP.

Different oral dosage forms are available, including oral paste, suspension and capsules, according to the veterinarian’s prescription.

The pharmacy states that the raw material used is pharmaceutically verified and that the preparations are made as part of its authorised compounding activity.

03

Why is the pharmaceutical pathway important?

Access through a veterinarian and an identifiable pharmacy allows:

  • 01

    prescribing a dose adapted to the individual case;

  • 02

    knowing the concentration of the preparation;

  • 03

    traceability of the source;

  • 04

    selecting a suitable dosage form;

  • 05

    monitoring treatment by the veterinarian;

  • 06

    avoiding products whose origin and composition are difficult to verify.

FIPvet recommends that FIP treatment be carried out only in collaboration with a veterinarian and through verifiable pharmaceutical sources.

View dosage forms, quantities and prices →